Company profile

Cardio-Phoenix Inc.

Cardio-Phoenix Inc. has 1 AI-enabled medical device on the FDA list. The first decision was on December 14, 2018 and the most recent on December 14, 2018 (Cardio-TriTest v6.5). Its most common review panel is Cardiovascular (1 device).

1AI devices

2018First decision

2018Latest decision

1Specialties

Timeline

December 14, 2018 · 510(k) K182790Cardio-TriTest v6.5 · Cardiovascular · DPS